RT @kuraoncology: We are excited to reveal KOMET-001, the name of the Phase 1/2A clinical trial of our menin inhibitor KO-539 in relapsed/r…
RT @kuraoncology: We are excited to reveal KOMET-001, the name of the Phase 1/2A clinical trial of our menin inhibitor KO-539 in relapsed/r…
© Nextech Invest Ltd. | privacy policy